Efgartigimod therapy for immune checkpoint inhibitor–associated myasthenia gravis with myositis: a case report
Abstract The advent of immune checkpoint inhibitors (ICIs) has transformed cancer therapy, but their association with immune-related adverse events presents a new and complex challenge for clinicians. In this report, we present the case of a 60-year-old Han Chinese woman who developed myasthenia gra...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
BMC
2025-07-01
|
| Цуврал: | BMC Neurology |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.1186/s12883-025-04288-0 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|